Use of the diode laser with intraoperative mitomycin C in endocanalicular laser dacryocystorhinostomy.
OBJECTIVE
To determine the safety and efficacy of the diode laser with intraoperative mitomycin C in endocanalicular laser dacryocystorhinostomy (ECL-DCR).


METHODS
In a prospective case series of 40 ECL-DCRs using the diode laser, mitomycin C was placed intraoperatively in all cases. The main outcome measure was resolution or improvement of epiphora and no major laser damage intranasally. Patients were followed for at least 18 months.


RESULTS
Forty consecutive ECL-DCRs on 30 patients (23 females, 7 males, mean age 62 years) were performed from April 2000 to December 2001. The success rate at 12 months postoperatively was 87.5%. All failures were due to a constricted nasal osteotomy. No significant intraoperative or postoperative complications were recorded.


CONCLUSIONS
Diode laser ECL-DCR with mitomycin C appears to be a safe and effective treatment modality for primary acquired nasolacrimal duct obstruction.
Henson
Raoul D
RD
St. Luke's International Eye Institute, St. Luke's Medical Center, Quezon City, Philippines. raoulhenson@gmail.com
Henson
Ruben G
RG
Cruz
Hernando L
HL
Camara
Jorge G
JG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000477:Alkylating Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003608:Dacryocystorhinostomy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007430:Intraoperative Care; D007767:Lacrimal Duct Obstruction / Q000188:drug therapy*; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage*; D009301:Nasolacrimal Duct; D011446:Prospective Studies; D016896:Treatment Outcome
D000477:Alkylating Agents; D016685:Mitomycin